Immatics
gen across all dose levels tolerability data | Immatics
Company
Deck Type
Sector
Industry
Deck date
November 2023
Slide
22 of 75
Similar slides by Immatics
See diffirences between slides (animation)
Investor Presentation
November 2023
gen at tolerability data | Immatics
Investor Presentation
November 2023
tolerability data cohort gen | Immatics
Results
October 2022
tolerability profile all grade adverse events voe | Immatics
Related slides by other companies
BioNTech
Results
August 2020
outlook for with melanoma update in enrollment | BioNTech
Nuvalent
Investor Presentation
April 2024
a global first in human phase clinical trial of in advanced alk positive and other solid tumors dose preliminary data presented all treated population enrollment completed updated data to be presented at medical meeting enrollment initiated june data cut off dose cohorts all doses patient population dose harboring alk fusion or activating mutation by local testing patients with prior or alk for dose optimization prior chemotherapies all treated population excluded concurrent drivers met ret or evaluable but non measurable disease allowed response evaluable population objectives selection if applicable primary overall safety tolerability characterization preliminary activity intracranial activity non small cell with cor evaluation per i platinum base dor duration response maximum cancer objective rate overall survival on free survival dose tyrosine kinase drivers identified on subsequent testing patients without measurable disease are excluded from efficacy time to response inhibitor without prior to the first response for response no measurable disease at tumor with driver met amplification no post scan discontinued treatment for reasons than tumor pancreatic atypical carcinoid lung source lin | Nuvalent
Valo
SPAC
June 2021
preclinical and phase i data suggests differentiated biology | Valo
Other recent decks by Immatics
See all presentations (2 decks)
Results
October 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights